Knee replacement, hip replacement and spine have been the most susceptible to disruption from procedure cancelations during the pandemic....
We estimate orthopedic sales grew in the mid-single digits for the first quarter of 2022 and that the remaining challenges...
Based on their commentary in the fourth quarter of 2021, orthopedic executives expect market disruption to persist through 2022....
Lower than average R&D spending combined with organizational challenges have slowed two of the largest orthopedic companies....
The orthopedic market finds itself in familiar territory in early 2022, with record COVID cases impacting elective surgery volumes....
Stryker and DePuy Synthes have grappled for the top spot in orthopedic sales for decades. We project that Stryker will...
As we near 2Q earnings, we're watching for a barometer of the market's recovery, momentum in M&A as well as...
ORTHOWORLD’s newest installment of THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT projects +14.6% growth in 2021 led by joint replacement and spine...
The first quarter of 2021 began amid COVID's deadliest surge. However, encouraging signs point toward a second half recovery....
We estimate the orthopedic market declined in the low single digits for 4Q20 and in the low double-digits for the...
0 
